3 High-Yield Pharmaceutical Stocks
Pharmaceutical stocks are generally an outstanding place to look for sustainable sources of passive income. Even though most companies offer fairly modest yields due to the costly nature of developing new drugs, there are a handful of big pharma stocks that do sport surprisingly high yields.
With this theme in mind, we asked three Motley Fool investors which high-yield pharma stocks might be worth buying right now. They recommended GlaxoSmithKline (NYSE: GSK), Pfizer (NYSE: PFE), and Johnson & Johnson (NYSE: JNJ).
Image source: Getty Images.
Source: Fool.com
Pfizer Inc. Stock
€21.71
0.790%
With 15 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 29 € there is a positive potential of 33.61% for Pfizer Inc. compared to the current price of 21.71 €.
